PT Anugerah Pharmindo Lestari Sustainability Profile
PT Anugerah Pharmindo Lestari, commonly known as Anugerah Pharmindo, is a prominent player in Indonesia's pharmaceutical industry, headquartered in Jakarta. Established in 1998, the company has made significant strides in the healthcare sector, focusing on the distribution and marketing of high-quality pharmaceutical products across the archipelago. With a robust portfolio that includes prescription medications, over-the-counter drugs, and health supplements, Anugerah Pharmindo is dedicated to enhancing the well-being of Indonesian communities. The company is recognised for its commitment to quality and innovation, ensuring that its products meet stringent regulatory standards. Anugerah Pharmindo has solidified its market position through strategic partnerships and a comprehensive distribution network, making it a trusted name among healthcare professionals and consumers alike. Its ongoing dedication to improving healthcare access underscores its role as a leader in the pharmaceutical landscape of Indonesia.
DitchCarbon Score
How does PT Anugerah Pharmindo Lestari's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
PT Anugerah Pharmindo Lestari's score of 32 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
PT Anugerah Pharmindo Lestari, headquartered in Indonesia, currently does not report specific carbon emissions data for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of Zuellig Pharma Holdings, which may influence its sustainability practices and reporting. As of now, PT Anugerah Pharmindo Lestari has not established any documented reduction targets or climate pledges. This lack of specific commitments suggests that the company may still be in the early stages of developing a comprehensive climate strategy. Given the context of the pharmaceutical industry, where sustainability and carbon footprint reduction are increasingly important, PT Anugerah Pharmindo Lestari may benefit from aligning with industry standards and initiatives to enhance its climate commitments. The absence of emissions data and reduction initiatives highlights an opportunity for the company to engage in more robust environmental practices and reporting in the future.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | - | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 49,336,336 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 76,839 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
How Carbon Intensive is PT Anugerah Pharmindo Lestari's Industry?
How Carbon Intensive is PT Anugerah Pharmindo Lestari's Location?
PT Anugerah Pharmindo Lestari's Scope 3 Categories Breakdown
PT Anugerah Pharmindo Lestari's Scope 3 emissions, which decreased by 36% last year and increased significantly since 2019, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 48% of Scope 3 emissions.
Top Scope 3 Categories
PT Anugerah Pharmindo Lestari's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
PT Anugerah Pharmindo Lestari has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
